International Clinical Trial: Comparative Bioavailability Study Between Ticagrelor and ASA Administered Individually or in Combination

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07444164) titled 'Comparative Bioavailability Study Between Ticagrelor and ASA Administered Individually or in Combination' on Feb. 24.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Laboratorios Silanes S.A. de C.V.

Condition: Healthy

Intervention: Drug: A1: Ticagrelor / Acetylsalicylic acid in fixed dose combination capsule. (Laboratorios Silanes S.A. de C.V.)

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: January 13, 2025

Target Sample Size: 24

Countries of...